clinical_trials
RFK Jr. Eases Access to Unproven Peptides Despite Opposition From FDA Scientists
Confidence86·multiple reportsImportance88NP-EVT-20261028-A810ED4
(MedPage Today) -- The Trump administration on Wednesday acted to ease access to unproven peptide drugs favored by Health Secretary Robert F. Kennedy Jr., and FDA scientific staffers had little input on the decision and opposed the changes, according...
Read the original at the primary source
RFK Jr. Eases Access to Unproven Peptides Despite Opposition From FDA Scientists
10/28/2026, 8:48:05 PM
Also on the network: airlinesairports · farmerspulse · foodpulse · indianhealthpulse · indias · keralahealth · naturepulse · travelerpulse
Discussion
ChatsPulse · 0 threads
No discussion yet. Sign in and start the first thread —